GrowBlox Sciences, Inc. (GBLX)

logo-2As medical marijuana gains more acceptance, many companies are now participating not only in distributing the product, but also in research and development to improve the production chain. GrowBlox Sciences, Inc is a company that offers solutions for cultivating and processing medical cannabis. Based in Las Vegas, Nevada, this development-stage company develops proprietary technologies that it intends to implement through state-level partners.

A primary technology of GrowBlox Sciences is the GrowBlox Cannabis Grow Chamber. It is an indoor plant-growing chamber with controlled climate and environmental parameters. Another is the InCUBEator Cannabis Propagation Chamber, which is used to ensure consistency in the tissue culture method of cannabis cultivation.

For the extraction of medicinal cannabis compounds, GrowBlox Sciences has ConversionLAB. It uses CO2 to help ensure that the extract is clean. In the final process of drying and curing, the company uses the CureBLOX Cannabis Drying System, which follows a specific algorithm for temperature and humidity. This makes the curing process and the product pathogen-free.

GrowBlox Sciences also presents itself as a leader in processing state and local licenses where there are medical cannabis programs. The company has specialists who cover standard application requests like compliance, security, branding, packaging, and sales plans.

Founded in 2001, GrowBlox Sciences, Inc started out as Flagstick Ventures, Inc. It became the Diabetic Treatment Centers of America, Inc in 2004, then Signature Exploration and Production Corp in 2008. Finally, it changed to GrowBlox Sciences, Inc in April 2014.

The company, valued at USD 22.41 M, currently trades in the OTC markets as GBLX. Its key executives are Craig M. Ellins, CEO and Chairman; Steven W. Weldon, CFO and Chief Accounting Officer; and Dr. Andrea Small-Howard, Chief Science Officer.

Yahoo! Finance: GBLX News

Latest Financial News for GBLX

GB Sciences Obtains Exclusive License for Patented Oral Thin Film Technology Containing Cannabis and Hemp-Derived Ingredients

GB Sciences Obtains Exclusive License for Patented Oral Thin Film Technology Containing Cannabis and Hemp-Derived Ingredients

GBS Global Biopharma and National Research Council of Canada Begin Preclinical Studies on Chronic-Neuropathic Pain Therapies

OTTAWA, Ontario, May 28, 2019 /PRNewswire/ -- GBS Global Biopharma, Inc. ("GBS Global"), a Canadian-based subsidiary of GB Sciences, Inc. (GBLX), announced preclinical studies on their proprietary chronic-neuropathic pain formulations in collaboration with the National Research Council ("NRC") Canada under the direction of Dr. Lee Ellis at NRC laboratories in Halifax, Nova Scotia. Growing public and government concerns regarding opioid abuse make novel pain treatments a promising field of research and development.

GB Sciences Prepares to Triple Production Capabilities in Its Las Vegas Facility

Positioned to Increase Revenue by Approximately $5.6 Million LAS VEGAS , May 14, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) today announced it is nearing completion of $700,000 in power and water ...

GB Sciences Louisiana Receives All Approvals and Announces the Opening of the Full Tissue Propagation Cannabis Cultivation at LSU Agricultural Center

Increases production and ensures a continuous supply of therapeutic cannabis for Louisiana patients. LAS VEGAS, April 16, 2019 /PRNewswire/ -- GB Sciences, Inc. (GBLX), a partner in GB Sciences Louisiana, LLC, is announcing that all cultivation operations at LSU Agricultural Center are now open. This will allow a continuous harvest for patients by increasing GB Sciences Louisiana's production capacity 500%.

Today: GB Sciences' Use of Controlled Cultivation, Product Formulations and Research Will Be Presented by Dr. Dominick Monaco at Cannabis Conference 2019, As Featured on Cover of Cannabis Business Times

LAS VEGAS, April 2, 2019 /PRNewswire/ -- GB Sciences, Inc. (GBLX) announced that Dr. Dominick Monaco, GB Sciences' Director of Medical Formulations, will be a featured speaker at the Las Vegas Cannabis Conference TODAY, April 2, at 4:40pm. Learn more here.